Fungal infection of implantable cardioverter-defibrillators: case series of five patients managed over 22 years

Heart Rhythm. 2006 Aug;3(8):919-23. doi: 10.1016/j.hrthm.2006.04.012. Epub 2006 Apr 20.

Abstract

Background: With the increasing use of implantable cardioverter-defibrillators (ICDs), device complications are becoming more common. Fungal-related ICD infections have rarely been reported, and little is known about the presentation, prevalence, and treatment options for these morbid infections.

Objectives: The purpose of this study was to characterize the clinical features, treatment, and outcomes of patients with fungal ICD infections.

Methods: We performed a retrospective review of ICD procedures performed at a single academic center and identified all ICD-related infections managed between 1983 and 2005.

Results: Among a total of 3,648 ICD-related procedures performed between 1983 and 2005, we identified 47 (1.3%) cases of ICD infections, of which 5 (0.1%) were due to a fungal pathogen. Fungal infections were more likely to be associated with abdominal devices, to have a local rather than systemic infection, and to have a longer duration from the original implant to presentation. All patients were treated with ICD system explantation and antifungal therapy.

Conclusion: Fungal infection of ICDs is a rare but serious complication of device implantation that must be treated aggressively with complete hardware explantation and prolonged antifungal therapy. Because most infections are late complications and have indolent onsets, a high level of clinical suspicion is required for early diagnosis.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Antifungal Agents / therapeutic use
  • Aspergillosis / diagnosis
  • Aspergillosis / drug therapy
  • Aspergillosis / etiology*
  • Aspergillosis / surgery
  • Aspergillus niger*
  • Candidiasis / diagnosis
  • Candidiasis / drug therapy
  • Candidiasis / etiology*
  • Candidiasis / surgery
  • Defibrillators, Implantable / adverse effects*
  • Echocardiography, Transesophageal
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prosthesis-Related Infections / diagnosis
  • Prosthesis-Related Infections / drug therapy
  • Prosthesis-Related Infections / etiology*
  • Prosthesis-Related Infections / surgery
  • Reoperation
  • Research Design
  • Retrospective Studies
  • Tachycardia, Ventricular / therapy
  • Tomography, X-Ray Computed
  • Ventricular Fibrillation / therapy

Substances

  • Antifungal Agents